CAM
REGN icon

Cozad Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Cozad Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-320
Closed -$203K – 413
2025
Q1 		$203K Sell
320
-2,953
-90% -$2.03M 0.02% 381
2024
Q4 		$2.33M Sell
3,273
-144
-4% -$121K 0.22% 113
2024
Q3 		$3.59M Sell
3,417
-34
-1% -$37.8K 0.34% 79
2024
Q2 		$3.63M Buy
3,451
+30
+0.9% +$29.1K 0.36% 71
2024
Q1 		$3.29M Sell
3,421
-220
-6% -$209K 0.34% 77
2023
Q4 		$3.2M Sell
3,641
-170
-4% -$140K 0.37% 76
2023
Q3 		$3.14M Sell
3,811
-3,275
-46% -$2.57M 0.41% 63
2023
Q2 		$5.09M Sell
7,086
-2,120
-23% -$1.63M 0.64% 38
2023
Q1 		$7.56M Buy
9,206
+1,190
+15% +$898K 1% 25
2022
Q4 		$5.78M Buy
8,016
+3,016
+60% +$2.23M 0.81% 35
2022
Q3 		$3.44M Buy
5,000
+1,620
+48% +$1.02M 0.56% 48
2022
Q2 		$2M Buy
3,380
+500
+17% +$325K 0.31% 98
2022
Q1 		$2.01M Buy
2,880
+250
+10% +$158K 0.28% 101
2021
Q4 		$1.66M Buy
+2,630
New +$1.62M 0.24% 111

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cozad Asset Management's REGN Position: Q2 2025 in Review

Cozad Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 320 shares — an estimated $203K sold.

Cozad Asset Management first reported a position in REGN in Q4 2021 and held it in 14 quarters. The position peaked at $7.56M in Q1 2023. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Cozad Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Cozad Asset Management sold 320 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $203K.
  • Cozad Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • Cozad Asset Management's Regeneron Pharmaceuticals position peaked at $7.56M in Q1 2023.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Cozad Asset Management's 13F filing for Q2 2025, filed 11 Aug 2025.